Neuromonitoring of Hepatic Encephalopathy

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Liver Failure, AcuteHepatic Encephalopathy
Interventions
DEVICE

Molecular Adsorbent Recirculating System (MARS)

MARS is an extracorporeal albumin dialysis device, used in the treatment of liver failure patients to stabilize the patient and halt the progression of HE, giving the liver time to recover in some cases and allowing additional time before liver transplantation in others.

Trial Locations (1)

00029

Helsinki University Central Hospital, Department of Anesthesiology and Intensive Care, Helsinki

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

University of Helsinki

OTHER